BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

363 related articles for article (PubMed ID: 1705001)

  • 1. Induction of deoxycytidine kinase by 5-azacytidine in an HL-60 cell line resistant to arabinosylcytosine.
    Kong XB; Tong WP; Chou TC
    Mol Pharmacol; 1991 Feb; 39(2):250-7. PubMed ID: 1705001
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of 5-azacytidine and congeners on DNA methylation and expression of deoxycytidine kinase in the human lymphoid cell lines CCRF/CEM/0 and CCRF/CEM/dCk-1.
    Antonsson BE; Avramis VI; Nyce J; Holcenberg JS
    Cancer Res; 1987 Jul; 47(14):3672-8. PubMed ID: 2439195
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Isolation and characterization of a deoxycytidine kinase-deficient human promyelocytic leukemic cell line highly resistant to 1-beta-D- arabinofuranosylcytosine.
    Bhalla K; Nayak R; Grant S
    Cancer Res; 1984 Nov; 44(11):5029-37. PubMed ID: 6091869
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacodynamic and DNA methylation studies of high-dose 1-beta-D-arabinofuranosyl cytosine before and after in vivo 5-azacytidine treatment in pediatric patients with refractory acute lymphocytic leukemia.
    Avramis VI; Mecum RA; Nyce J; Steele DA; Holcenberg JS
    Cancer Chemother Pharmacol; 1989; 24(4):203-10. PubMed ID: 2473850
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cystathionine-beta-synthase cDNA transfection alters the sensitivity and metabolism of 1-beta-D-arabinofuranosylcytosine in CCRF-CEM leukemia cells in vitro and in vivo: a model of leukemia in Down syndrome.
    Taub JW; Huang X; Ge Y; Dutcher JA; Stout ML; Mohammad RM; Ravindranath Y; Matherly LH
    Cancer Res; 2000 Nov; 60(22):6421-6. PubMed ID: 11103808
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A critical role for uridine nucleotides in the regulation of deoxycytidine kinase and the concentration dependence of 1-beta-D-arabinofuranosylcytosine phosphorylation in human leukemia cells.
    White JC; Capizzi RL
    Cancer Res; 1991 May; 51(10):2559-65. PubMed ID: 2021937
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Metabolism of 1-beta-D-arabinofuranosyl-5-azacytosine and incorporation into DNA of human T-lymphoblastic cells (Molt-4).
    Townsend A; Leclerc JM; Dutschman G; Cooney D; Cheng YC
    Cancer Res; 1985 Aug; 45(8):3522-8. PubMed ID: 2410096
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Potentiation of the activity of 1-beta-D-arabinofuranosylcytosine by the protein kinase C activator bryostatin 1 in HL-60 cells: association with enhanced fragmentation of mature DNA.
    Grant S; Jarvis WD; Swerdlow PS; Turner AJ; Traylor RS; Wallace HJ; Lin PS; Pettit GR; Gewirtz DA
    Cancer Res; 1992 Nov; 52(22):6270-8. PubMed ID: 1423273
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intracellular cytarabine triphosphate production correlates to deoxycytidine kinase/cytosolic 5'-nucleotidase II expression ratio in primary acute myeloid leukemia cells.
    Yamauchi T; Negoro E; Kishi S; Takagi K; Yoshida A; Urasaki Y; Iwasaki H; Ueda T
    Biochem Pharmacol; 2009 Jun; 77(12):1780-6. PubMed ID: 19428333
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of deoxycytidine kinase in an in vitro model for AraC- and DAC-resistance: substrate-enzyme interactions with deoxycytidine, 1-beta-D-arabinofuranosylcytosine and 5-aza-2'-deoxycytidine.
    Stegmann AP; Honders MW; Kester MG; Landegent JE; Willemze R
    Leukemia; 1993 Jul; 7(7):1005-11. PubMed ID: 7686601
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Substrate-specific deoxycytidine kinase deficiency in 1-beta-D-arabinofuranosylcytosine-resistant leukemic cells.
    Richel DJ; Colly LP; Arkesteijn GJ; Arentsen-Honders MW; Kerster MG; ter Riet PM; Willemze R
    Cancer Res; 1990 Oct; 50(20):6515-9. PubMed ID: 2208110
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characterization of a multidrug resistant human erythroleukemia cell line (K562) exhibiting spontaneous resistance to 1-beta-D-arabinofuranosylcytosine.
    Grant S; Turner A; Nelms P; Yanovich S
    Leukemia; 1995 May; 9(5):808-14. PubMed ID: 7769843
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cellular phosphorylation of 1-beta-D-arabinofuranosylcytosine 5-azacytidine with intact fibrosarcoma and leukemic cells.
    Lee T; Karon M; Monparler RL
    Cancer Res; 1975 Sep; 35(9):2506-10. PubMed ID: 50132
    [TBL] [Abstract][Full Text] [Related]  

  • 14. De novo induced mutations in the deoxycytidine kinase (dck) gene in rat leukemic clonal cell lines confer resistance to cytarabine (AraC) and 5-aza-2'-deoxycytidine (DAC).
    Stegmann AP; Honders MW; Willemze R; Landegent JE
    Leukemia; 1995 Jun; 9(6):1032-8. PubMed ID: 7541096
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 1-beta-D-arabinofuranosylcytosine metabolism and incorporation into DNA as determinants of in vivo murine tumor cell response.
    Riva CM; Rustum YM
    Cancer Res; 1985 Dec; 45(12 Pt 1):6244-9. PubMed ID: 2998596
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Arabinosylguanine is phosphorylated by both cytoplasmic deoxycytidine kinase and mitochondrial deoxyguanosine kinase.
    Rodriguez CO; Mitchell BS; Ayres M; Eriksson S; Gandhi V
    Cancer Res; 2002 Jun; 62(11):3100-5. PubMed ID: 12036920
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antiproliferative activity and mechanism of action of fatty acid derivatives of arabinofuranosylcytosine in leukemia and solid tumor cell lines.
    Bergman AM; Kuiper CM; Voorn DA; Comijn EM; Myhren F; Sandvold ML; Hendriks HR; Peters GJ
    Biochem Pharmacol; 2004 Feb; 67(3):503-11. PubMed ID: 15037202
    [TBL] [Abstract][Full Text] [Related]  

  • 18. 1-beta-D-arabinofuranosylcytosine activates serine/threonine protein kinases and c-jun gene expression in phorbol ester-resistant myeloid leukemia cells.
    Kharbanda S; Emoto Y; Kisaki H; Saleem A; Kufe D
    Mol Pharmacol; 1994 Jul; 46(1):67-72. PubMed ID: 8058058
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vitro biochemical and cytotoxicity studies with 1-beta-D-arabinofuranosylcytosine and 5-azacytidine in combination.
    Momparler RL; Goodman J; Karon M
    Cancer Res; 1975 Oct; 35(10):2853-7. PubMed ID: 50882
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sequence-specific effects of ara-5-aza-CTP and ara-CTP on DNA synthesis by purified human DNA polymerases in vitro: visualization of chain elongation on a defined template.
    Townsend AJ; Cheng YC
    Mol Pharmacol; 1987 Sep; 32(3):330-9. PubMed ID: 2444869
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.